1. Home
  2. CRDF vs PAL Comparison

CRDF vs PAL Comparison

Compare CRDF & PAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDF
  • PAL
  • Stock Information
  • Founded
  • CRDF 1999
  • PAL 2023
  • Country
  • CRDF United States
  • PAL United States
  • Employees
  • CRDF N/A
  • PAL N/A
  • Industry
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • PAL
  • Sector
  • CRDF Health Care
  • PAL
  • Exchange
  • CRDF Nasdaq
  • PAL NYSE
  • Market Cap
  • CRDF 196.2M
  • PAL 205.7M
  • IPO Year
  • CRDF N/A
  • PAL 2024
  • Fundamental
  • Price
  • CRDF $2.66
  • PAL $7.18
  • Analyst Decision
  • CRDF Strong Buy
  • PAL Strong Buy
  • Analyst Count
  • CRDF 4
  • PAL 4
  • Target Price
  • CRDF $12.25
  • PAL $16.00
  • AVG Volume (30 Days)
  • CRDF 1.1M
  • PAL 315.6K
  • Earning Date
  • CRDF 05-08-2025
  • PAL 05-07-2025
  • Dividend Yield
  • CRDF N/A
  • PAL N/A
  • EPS Growth
  • CRDF N/A
  • PAL N/A
  • EPS
  • CRDF N/A
  • PAL N/A
  • Revenue
  • CRDF $587,000.00
  • PAL $336,060,548.00
  • Revenue This Year
  • CRDF N/A
  • PAL $85.66
  • Revenue Next Year
  • CRDF N/A
  • PAL $14.40
  • P/E Ratio
  • CRDF N/A
  • PAL N/A
  • Revenue Growth
  • CRDF N/A
  • PAL N/A
  • 52 Week Low
  • CRDF $2.01
  • PAL $6.81
  • 52 Week High
  • CRDF $5.64
  • PAL $21.01
  • Technical
  • Relative Strength Index (RSI)
  • CRDF 42.40
  • PAL N/A
  • Support Level
  • CRDF $2.42
  • PAL N/A
  • Resistance Level
  • CRDF $2.87
  • PAL N/A
  • Average True Range (ATR)
  • CRDF 0.19
  • PAL 0.00
  • MACD
  • CRDF 0.01
  • PAL 0.00
  • Stochastic Oscillator
  • CRDF 27.91
  • PAL 0.00

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

About PAL PROFICIENT AUTO LOGISTICS INC

Proficient Auto Logistics Inc is a non-union, specialized freight company focused on providing auto transportation and logistics services. The company operates auto transportation fleets in North America based upon information obtained from the Auto Haulers Association of America, utilizing auto transport vehicles and trailers daily, including Company-owned transport vehicles and trailers. The reportable revenue categories of the company are Truckload and Brokerage. The company derives maximum revenue from the brokerage segment that retains the customer relationship, including billing and collection, and outsources the transportation of the loads to third-party carriers.

Share on Social Networks: